DEA extends telehealth prescription waivers, puts proposed rules on hold
Advocacy groups, specialty societies and medical providers praised the extension of waivers that allow practices to prescribe controlled substances via telehealth. The extension will run until Nov. 11, 2024, if a patient establishes a telehealth relationship with a provider by Nov. 11, 2023.
To read the full article, sign in and subscribe to the DecisionHealth Newsletters.